IL152410A0 - Method for cell adhesion and wound healing - Google Patents

Method for cell adhesion and wound healing

Info

Publication number
IL152410A0
IL152410A0 IL15241000A IL15241000A IL152410A0 IL 152410 A0 IL152410 A0 IL 152410A0 IL 15241000 A IL15241000 A IL 15241000A IL 15241000 A IL15241000 A IL 15241000A IL 152410 A0 IL152410 A0 IL 152410A0
Authority
IL
Israel
Prior art keywords
wound healing
βig
cell adhesion
internal
recombinant proteins
Prior art date
Application number
IL15241000A
Other languages
English (en)
Original Assignee
Regen Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regen Biotech Inc filed Critical Regen Biotech Inc
Publication of IL152410A0 publication Critical patent/IL152410A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
IL15241000A 2000-05-13 2000-12-08 Method for cell adhesion and wound healing IL152410A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2000-0025662A KR100385293B1 (ko) 2000-05-13 2000-05-13 βig-h3의 일부 도메인을 이용한 세포 부착 및 창상치유 방법
PCT/KR2000/001428 WO2001087327A1 (en) 2000-05-13 2000-12-08 Method for cell adhesion and wound healing

Publications (1)

Publication Number Publication Date
IL152410A0 true IL152410A0 (en) 2003-05-29

Family

ID=19668565

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15241000A IL152410A0 (en) 2000-05-13 2000-12-08 Method for cell adhesion and wound healing
IL200132A IL200132A0 (en) 2000-05-13 2009-07-29 Method for cell adhesion and wound healing

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL200132A IL200132A0 (en) 2000-05-13 2009-07-29 Method for cell adhesion and wound healing

Country Status (12)

Country Link
US (2) US7396682B2 (enExample)
EP (1) EP1282434B1 (enExample)
JP (1) JP3795805B2 (enExample)
KR (1) KR100385293B1 (enExample)
CN (1) CN1209165C (enExample)
AT (1) ATE446765T1 (enExample)
AU (2) AU2027001A (enExample)
CA (1) CA2409506A1 (enExample)
DE (1) DE60043238D1 (enExample)
IL (2) IL152410A0 (enExample)
RU (1) RU2234937C2 (enExample)
WO (1) WO2001087327A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8258260B2 (en) * 1970-02-11 2012-09-04 Immatics Biotechnologies Gmbh Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules
KR100378949B1 (ko) * 2000-05-13 2003-04-08 주식회사 리젠 바이오텍 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체
US20050164197A1 (en) * 2002-04-19 2005-07-28 In-San Kim Method for measuring the amount of betaig-h3 protein and diagnostic kit using the same
US20080274955A1 (en) * 2004-04-13 2008-11-06 Kyungpook National University Industry Academic Cooperation Foundation Novel Use of a Polypeptide Comprising Fas-1 Domain
KR100635540B1 (ko) * 2004-10-12 2006-10-18 경북대학교 산학협력단 신규한 염증성 질환의 예방 또는 치료용 약학적 조성물
RU2288663C1 (ru) * 2005-05-03 2006-12-10 Государственное учреждение Самарский государственный медицинский университет Способ лечения посттравматического остеомиелита
RU2458069C2 (ru) * 2007-01-05 2012-08-10 Хеликс Байомедикс Инк. Выделенный пептид для усиления ранозаживляющей активности кератиноцитов, композиция для заживления ран у млекопитающего и лекарственное средство для применения при заживлении ран у млекопитающего
JP2012012344A (ja) * 2010-07-01 2012-01-19 Japan Health Science Foundation 創傷治癒剤
CN108586584A (zh) * 2018-05-03 2018-09-28 杭州史迪姆生物科技有限公司 功能多肽及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983581A (en) * 1988-05-20 1991-01-08 Institute Of Molecular Biology, Inc. Wound healing composition of IGF-I and TGF-β
JP3377524B2 (ja) * 1990-05-30 2003-02-17 プレジデント アンド フェロウズ オブ ハーバード カレッジ 創傷治癒
HUT67319A (en) * 1991-08-30 1995-03-28 Life Medical Sciences Inc Compositions for treating wounds
US5444164A (en) * 1992-02-05 1995-08-22 Bristol-Myers Squibb Company TGF-β induced gene
US5599788A (en) * 1994-07-01 1997-02-04 Advanced Tissue Sciences Method for accelerating skin wound healing with H3 protein
KR100378949B1 (ko) * 2000-05-13 2003-04-08 주식회사 리젠 바이오텍 세포 부착, 확산 및 탈착 활성을 나타내는 펩타이드 및그의 유도체

Also Published As

Publication number Publication date
EP1282434B1 (en) 2009-10-28
CN1209165C (zh) 2005-07-06
EP1282434A4 (en) 2004-12-08
KR20010104176A (ko) 2001-11-24
US20100331253A9 (en) 2010-12-30
WO2001087327A1 (en) 2001-11-22
DE60043238D1 (de) 2009-12-10
IL200132A0 (en) 2010-04-15
KR100385293B1 (ko) 2003-05-23
RU2234937C2 (ru) 2004-08-27
US20080214463A1 (en) 2008-09-04
JP2004521605A (ja) 2004-07-22
JP3795805B2 (ja) 2006-07-12
AU2027001A (en) 2001-11-26
CA2409506A1 (en) 2001-11-22
RU2002133463A (ru) 2004-03-27
AU2001220270B2 (en) 2004-09-30
EP1282434A1 (en) 2003-02-12
US20040052767A1 (en) 2004-03-18
CN1452493A (zh) 2003-10-29
ATE446765T1 (de) 2009-11-15
US7396682B2 (en) 2008-07-08

Similar Documents

Publication Publication Date Title
IL200132A0 (en) Method for cell adhesion and wound healing
DE60031419D1 (de) Zusammensetzungen und verfahren für verbesserte zellkultur
ATE500323T1 (de) Subtilisin-variante
DE60232234D1 (de) Verfahren zur kultivierung von circovirus
ATE465748T1 (de) Vernetzte, nicht von pilzen kommende lipase enthaltende zusammensetzung und methoden zu deren verwendung
WO2002016583A3 (en) Constructs and their use in metabolic pathway engineering
DE69712003D1 (de) Modifikation von xylanase zur Verbesserung von Thermophilicität, alkophilicität und thermostabilität
ATE376434T1 (de) Injektionsgerät für mrna applikation
DE60231395D1 (de) Dezellularisierung von gewebematrixen
NZ516400A (en) Stable factor VIII compositions
DE60137978D1 (de) Zusammensetzung zur förderung des haarwachstums
TR200400639T4 (tr) Donmaya-karşı proteinler, bunların üretimleri ve kullanımları
DE60107718T8 (de) Konservierung von zellen
DE50105373D1 (de) Dipeptidische hemmstoffe für den gerinnungsfaktor xa
DE59508100D1 (de) Verwendung von zelladhäsions-peptiden zur modifikation des haftungsvermögens eukaryontischer zellen untereinander
WO2002004521A3 (en) Proteins with integrin-like activity
TR200100013T2 (tr) N-tert-butilhidroksilaminin yeni tuzları.
DE50010015D1 (de) Tetrahydropyrimidin-dioxygenase-gen, dadurch kodierte polypeptide und verfahren zur deren herstellung
BR9800928A (pt) Material cosmético, e, processo para preparar o mesmo.
MXPA02007787A (es) Moleculas trade y uso relacionado con las mismas.
ATE315093T1 (de) Hcv ns2/3 fragmente und ihre verwendungen
EP1117419A4 (en) Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions
AU2002229850A1 (en) Polypeptide inducing hiv-neutralising antibodies
ATE319820T1 (de) Verfahren zur inaktivierung von amylase in gegenwart von protease
EA200000946A1 (ru) Кристаллическая форма пароксетина